Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Wei Quan, Yuan Wang, Yu-han Chen, Qing Shao, Yang-ze Gong, Jie-wen Hu, Wei-hai Liu, Zi-jun Wu, Jie Wang, Shan-bo Ma & Xiao-qiang Li. (2023) Screening of rosmarinic acid from Salvia miltiorrhizae acting on the novel target TRPC1 based on the ‘homology modelling–virtual screening–molecular docking–affinity assay–activity evaluation’ method. Pharmaceutical Biology 61:1, pages 155-164.
Read now
Read now
Moulay Ahfid El Alaouy, Marwa Alaqarbeh, Mohamed Ouabane, Hanane Zaki, Mohamed ElBouhi, Hassan Badaoui, Youness Moukhliss, Abdelouahid Sbai, Hamid Maghat, Tahar Lakhlifi & Mohammed Bouachrine. (2023) Computational Prediction of 3,5-Diaryl-1H-Pyrazole and spiropyrazolines derivatives as potential acetylcholinesterase inhibitors for alzheimer disease treatment by 3D-QSAR, molecular docking, molecular dynamics simulation, and ADME-Tox. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-14.
Read now
Read now
Ivan Yu. Torshin, Vladimir A. Namiot, Natalia G. Esipova & Vladimir G. Tumanyan. (2021) Numeric analysis of reversibility of classic movement equations and constructive criteria of estimating quality of molecular dynamic simulations. Journal of Biomolecular Structure and Dynamics 39:11, pages 4066-4076.
Read now
Read now
Ying Wang, Johnson Joseph, Yinli Gao, Baichun Hu, Xiaohui Geng, Di Wu, Jian Wang & Fengjiao Zhang. (2021) Revealing the interaction modes of 5-HT2A receptor antagonists and the Structure-Based virtual screening from FDA and TCMNP database. Journal of Biomolecular Structure and Dynamics 39:10, pages 3681-3692.
Read now
Read now
Milica Radan, Dusan Ruzic, Mirjana Antonijevic, Teodora Djikic & Katarina Nikolic. (2021) In silico identification of novel 5-HT2A antagonists supported with ligand- and target-based drug design methodologies. Journal of Biomolecular Structure and Dynamics 39:5, pages 1819-1837.
Read now
Read now
Anu Manhas, Saikat Dubey & Prakash C. Jha. (2020) A profound computational study to prioritize the natural compound inhibitors against the P. falciparum orotidine-5-monophosphate decarboxylase enzyme. Journal of Biomolecular Structure and Dynamics 38:9, pages 2704-2716.
Read now
Read now
Articles from other publishers (16)
Radomir Juza, Kamil Musilek, Eva Mezeiova, Ondrej Soukup & Jan Korabecny. (2022)
Recent advances in dopamine D
2
receptor ligands in the treatment of neuropsychiatric disorders
. Medicinal Research Reviews 43:1, pages 55-211.
Crossref
Crossref
Parisa Amani, Razieh Habibpour & Leila Karami. (2022) Characterizing aripiprazole and its ester derivatives, lauroxil and cavoxil, in interaction with dopamine D2 receptor: Molecular docking and dynamics simulations with physicochemical appraisals. Journal of Molecular Liquids 362, pages 119787.
Crossref
Crossref
Milica Radan, Teodora Djikic & Katarina Nikolic. (2022)
Discovery of new chemotypes of dual 5-HT
2A
/D
2
receptor antagonists with a strategy of drug design methodologies
. Future Medicinal Chemistry 14:13, pages 963-989.
Crossref
Crossref
Akash Rathore, Vivek Asati, Mitali Mishra, Ratnesh Das, Varsha Kashaw & Sushil Kumar Kashaw. (2022) Computational approaches for the design of novel dopamine D2 and serotonin 5-HT2A receptor dual antagonist towards schizophrenia. In Silico Pharmacology 10:1.
Crossref
Crossref
Antonio Abad-García, A. Lilia Ocampo-Néstor, Bhaskar C. Das, Eunice D. Farfán-García, Martiniano Bello, José G. Trujillo-Ferrara & Marvin A. Soriano-Ursúa. (2021) Interactions of a boron-containing levodopa derivative on D2 dopamine receptor and its effects in a Parkinson disease model. JBIC Journal of Biological Inorganic Chemistry 27:1, pages 121-131.
Crossref
Crossref
Agata Zięba, Piotr Stępnicki, Dariusz Matosiuk & Agnieszka A. Kaczor. (2021) Overcoming Depression with 5-HT2A Receptor Ligands. International Journal of Molecular Sciences 23:1, pages 10.
Crossref
Crossref
Danko Jeremic, Irene Sanchez-Rodriguez, Lydia Jimenez-Diaz & Juan D. Navarro-Lopez. (2021) Therapeutic potential of targeting G protein-gated inwardly rectifying potassium (GIRK) channels in the central nervous system. Pharmacology & Therapeutics 223, pages 107808.
Crossref
Crossref
Tomasz Boczek, Joanna Mackiewicz, Marta Sobolczyk, Julia Wawrzyniak, Malwina Lisek, Bozena Ferenc, Feng Guo & Ludmila Zylinska. (2021) The Role of G Protein-Coupled Receptors (GPCRs) and Calcium Signaling in Schizophrenia. Focus on GPCRs Activated by Neurotransmitters and Chemokines. Cells 10:5, pages 1228.
Crossref
Crossref
Shahrukh Qureshi, Ravina Khandelwal, Maddala Madhavi, Naveesha Khurana, Neha Gupta, Saurav K. Choudhary, Revathy A. Suresh, Lima Hazarika, Chillamcherla D. Srija, Khushboo Sharma, Mali R. Hindala, Tajamul Hussain, Anuraj Nayarisseri & Sanjeev K. Singh. (2021) A Multi-target Drug Designing for BTK, MMP9, Proteasome and TAK1 for the Clinical Treatment of Mantle Cell Lymphoma. Current Topics in Medicinal Chemistry 21:9, pages 790-818.
Crossref
Crossref
Anuraj Nayarisseri, Ravina Khandelwal, Poonam Tanwar, Maddala Madhavi, Diksha Sharma, Garima Thakur, Alejandro Speck-Planche & Sanjeev Kumar Singh. (2021) Artificial Intelligence, Big Data and Machine Learning Approaches in Precision Medicine & Drug Discovery. Current Drug Targets 22:6, pages 631-655.
Crossref
Crossref
Hadiza Lawal Abdulrahman, Adamu Uzairu & Sani Uba. (2020) Computer modeling of some anti-breast cancer compounds. Structural Chemistry 32:2, pages 679-687.
Crossref
Crossref
Milica Radan, Jelena Bošković, Vladimir Dobričić, Olivera Čudina & Katarina Nikolić. (2021) Current computer-aided drug design methodologies in discovery of novel drug candidates for neuropsychiatric and inflammatory diseases. Arhiv za farmaciju 71:4, pages 225-256.
Crossref
Crossref
Hadiza Abdulrahman Lawal, Adamu Uzairu & Sani Uba. (2020) QSAR, molecular docking, design, and pharmacokinetic analysis of 2-(4-fluorophenyl) imidazol-5-ones as anti-breast cancer drug compounds against MCF-7 cell line. Journal of Bioenergetics and Biomembranes 52:6, pages 475-494.
Crossref
Crossref
Jon DelaCuesta-Barrutia, Olga Peñagarikano & Amaia M. Erdozain. (2020) G Protein-Coupled Receptor Heteromers as Putative Pharmacotherapeutic Targets in Autism. Frontiers in Cellular Neuroscience 14.
Crossref
Crossref
Jean Claude Martel & Silvia Gatti McArthur. (2020) Dopamine Receptor Subtypes, Physiology and Pharmacology: New Ligands and Concepts in Schizophrenia. Frontiers in Pharmacology 11.
Crossref
Crossref
Pradeep Paudel, Se Eun Park, Su Hui Seong, Hyun Ah Jung & Jae Sue Choi. (2019) Novel Diels–Alder Type Adducts from Morus alba Root Bark Targeting Human Monoamine Oxidase and Dopaminergic Receptors for the Management of Neurodegenerative Diseases. International Journal of Molecular Sciences 20:24, pages 6232.
Crossref
Crossref